Michael Pfreundschuh
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 09, 2020
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.Gerald G Wulf, Bettina Altmann, Marita Ziepert
|Jun 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting.Lorenz Thurner, Sylvia Hartmann, Natalie Fadle
|May 04, 2018
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.Peter Paschka, Richard F Schlenk, Daniela Weber
|Feb 27, 2018
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.Susanne Saussele, Rüdiger Hehlmann, Alice Fabarius
|Oct 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.Michael Pfreundschuh, Niels Murawski, Samira Zeynalova
|Sep 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.Hermann Einsele, Monika Engelhardt, Christoph Tapprich
Pageof 1
